Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.

Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS.

Science. 2010 Aug 20;329(5994):959-64. doi: 10.1126/science.1190287.

2.

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.

George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA.

Arch Gen Psychiatry. 2010 May;67(5):507-16. doi: 10.1001/archgenpsychiatry.2010.46.

PMID:
20439832
3.

Bipolar depression: overview and commentary.

Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL.

Harv Rev Psychiatry. 2010 May-Jun;18(3):143-57. doi: 10.3109/10673221003747955. Review.

PMID:
20415631
4.

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

Amsterdam JD, Shults J.

Am J Psychiatry. 2010 Jul;167(7):792-800. doi: 10.1176/appi.ajp.2009.09020284. Epub 2010 Apr 1.

5.

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE.

Mov Disord. 2010 Apr 15;25(5):578-86. doi: 10.1002/mds.22735.

PMID:
20213817
6.

Minding one's emotions: mindfulness training alters the neural expression of sadness.

Farb NA, Anderson AK, Mayberg H, Bean J, McKeon D, Segal ZV.

Emotion. 2010 Feb;10(1):25-33. doi: 10.1037/a0017151. Erratum in: Emotion. 2010 Apr;10(2):215.

7.

Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.

Drevets WC, Furey ML.

Biol Psychiatry. 2010 Mar 1;67(5):432-8. doi: 10.1016/j.biopsych.2009.11.021. Epub 2010 Jan 15.

8.

Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.

Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE.

Biol Psychiatry. 2010 Jan 15;67(2):110-6. doi: 10.1016/j.biopsych.2009.09.013.

PMID:
19914605
9.

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ.

Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038.

PMID:
19897179
10.

Unilateral pedunculopontine stimulation improves falls in Parkinson's disease.

Moro E, Hamani C, Poon YY, Al-Khairallah T, Dostrovsky JO, Hutchison WD, Lozano AM.

Brain. 2010 Jan;133(Pt 1):215-24. doi: 10.1093/brain/awp261. Epub 2009 Oct 21.

PMID:
19846583
11.

Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient.

Sartorius A, Kiening KL, Kirsch P, von Gall CC, Haberkorn U, Unterberg AW, Henn FA, Meyer-Lindenberg A.

Biol Psychiatry. 2010 Jan 15;67(2):e9-e11. doi: 10.1016/j.biopsych.2009.08.027. No abstract available.

PMID:
19846068
12.

Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression.

Nahas Z, Anderson BS, Borckardt J, Arana AB, George MS, Reeves ST, Takacs I.

Biol Psychiatry. 2010 Jan 15;67(2):101-9. doi: 10.1016/j.biopsych.2009.08.021.

13.

The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.

Carpenter WT, Bustillo JR, Thaker GK, van Os J, Krueger RF, Green MJ.

Psychol Med. 2009 Dec;39(12):2025-42. doi: 10.1017/S0033291709990286. Epub 2009 Oct 1. Review.

PMID:
19796428
14.

Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.

Thase ME.

Neuropsychopharmacology. 2009 Dec;34(13):2633-41. doi: 10.1038/npp.2009.100. Epub 2009 Sep 9. Review.

15.

Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements.

Katz MM, Bowden CL, Frazer A.

J Affect Disord. 2010 Jan;120(1-3):16-23. doi: 10.1016/j.jad.2009.08.011. Review.

PMID:
19735945
16.

Neurocircuitry of mood disorders.

Price JL, Drevets WC.

Neuropsychopharmacology. 2010 Jan;35(1):192-216. doi: 10.1038/npp.2009.104. Review.

17.

The role of beta-endorphin in the pathophysiology of major depression.

Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N.

Neuropeptides. 2009 Oct;43(5):341-53. doi: 10.1016/j.npep.2009.06.004. Epub 2009 Aug 3. Review.

PMID:
19647870
18.

Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity.

Hunsberger JG, Austin DR, Chen G, Manji HK.

Brain Res. 2009 Oct 13;1293:76-84. doi: 10.1016/j.brainres.2009.06.103. Epub 2009 Jul 10. Review.

19.

Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.

Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, Isenberg K, Garcia K, Mulsant BH, Haskett RF.

Arch Gen Psychiatry. 2009 Jul;66(7):729-37. doi: 10.1001/archgenpsychiatry.2009.75.

PMID:
19581564
20.

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Savitz J, Drevets WC.

Neurosci Biobehav Rev. 2009 May;33(5):699-771. doi: 10.1016/j.neubiorev.2009.01.004. Epub 2009 Jan 21. Review.

Supplemental Content

Support Center